Latest news
Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... - Yahoo Finance UKYahoo Finance UK · Mon, 10 Aug 2026 21:01:41 GMTOPTU Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Strategic Refocusing - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 05:25:00 GMTHCAT Q2 Deep Dive: Vitalware Divestiture Reshapes Strategy Amid Revenue Decline - StockStoryStockStory · Fri, 07 Aug 2026 07:00:00 GMTProgyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Revenue and EBITDA Amid Strategic ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:06:00 GMTONIT: Record origination and double-digit revenue growth achieved amid strategic simplification and tech-driven gains - tradingview.comtradingview.com · Thu, 06 Aug 2026 13:47:18 GMTBLNK: Q2 2026 saw improved margins and reduced losses amid lower revenue and strategic restructuring - tradingview.comtradingview.com · Thu, 06 Aug 2026 10:04:09 GMTBCO Q2 Deep Dive: Margin Expansion and Strategic Growth Amid NCR Atleos Integration - StockStoryStockStory · Thu, 06 Aug 2026 09:02:09 GMTSR SWOT Analysis: Strong Revenue Growth Amidst Strategic Divesti - GuruFocusGuruFocus · Thu, 06 Aug 2026 05:23:37 GMT